{{Rsnum
|rsid=10151731
|Gene=NRXN3
|Chromosome=14
|position=78739276
|Orientation=plus
|GMAF=0.2534
|Gene_s=NRXN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.9 | 29.2 | 69.9
| HCB | 2.9 | 24.1 | 73.0
| JPT | 6.2 | 35.4 | 58.4
| YRI | 31.3 | 53.7 | 15.0
| ASW | 12.3 | 61.4 | 26.3
| CHB | 2.9 | 24.1 | 73.0
| CHD | 3.7 | 29.4 | 67.0
| GIH | 7.9 | 49.5 | 42.6
| LWK | 40.9 | 42.7 | 16.4
| MEX | 1.7 | 17.2 | 81.0
| MKK | 41.3 | 46.5 | 12.3
| TSI | 1.0 | 31.4 | 67.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23245376
|Title=Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}